Adage Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.9M | Sell |
|
|||||
|
2025
Q2 | $55.6M | Sell |
|
|||||
|
2025
Q1 | $77.8M | Buy |
|
|||||
|
2024
Q4 | $49.8M | Sell |
|
|||||
|
2024
Q3 | $84.8M | Buy |
|
|||||
|
2024
Q2 | $46.2M | Buy |
|
|||||
|
2024
Q1 | $7M | Sell |
|
|||||
|
2023
Q4 | $49M | Buy |
|
|||||
|
2023
Q3 | $3.21M | Sell |
|
|||||
|
2023
Q2 | $4.96M | Sell |
|
|||||
|
2023
Q1 | $4.89M | Sell |
|
|||||
|
2022
Q4 | $6.49M | Sell |
|
|||||
|
2022
Q3 | $6.42M | Sell |
|
|||||
|
2022
Q2 | $40.6M | Sell |
|
|||||
|
2022
Q1 | $50.8M | Hold |
|
|||||
|
2021
Q4 | $58.9M | Buy |
|
|||||
|
2021
Q3 | $55.9M | Buy |
|
|||||
|
2021
Q2 | $24.8M | Buy |
|
|||||
|
2021
Q1 | $21.1M | Buy |
|
|||||
|
2020
Q4 | $22.9M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.4M | Sell |
|
|||||
|
2018
Q2 | $25.2M | Sell |
|
|||||
|
2018
Q1 | $24.9M | Buy |
|
|||||
|
2017
Q4 | $4.99M | Sell |
|
|||||
|
2017
Q3 | $10M | Sell |
|
|||||
|
2017
Q2 | $29M | Buy |
|
|||||
|
2017
Q1 | $9.52M | Sell |
|
|||||
|
2016
Q4 | $44.2M | Sell |
|
|||||
|
2016
Q3 | $48.1M | Buy |
|
|||||
|
2016
Q2 | $31.2M | Buy |
|
|||||
|
2016
Q1 | $30.6M | Buy |
|
|||||
|
2015
Q4 | $37.4M | Sell |
|
|||||
|
2015
Q3 | $42.2M | Sell |
|
|||||
|
2015
Q2 | $64M | Sell |
|
|||||
|
2015
Q1 | $59M | Sell |
|
|||||
|
2014
Q4 | $46.8M | Buy |
|
|||||
|
2014
Q3 | $59.4M | Sell |
|
|||||
|
2014
Q2 | $78.9M | Sell |
|
|||||
|
2014
Q1 | $90M | Buy |
|